Related Experiment Videos
Recombinational DNA repair and human disease
Larry H Thompson1, David Schild
1Biology and Biotechnology Research Program, Lawrence Livermore National Laboratory L-441, P.O. Box 808, Livermore, CA 94551-0808, USA. thompson14@llnl.gov
Mutation Research
|November 13, 2002
Summary
Homologous recombinational repair (HRR) pathway genes are crucial in preventing cancer by maintaining chromosome stability. Defects in HRR genes lead to genetic disorders and mutations, increasing cancer risk.
Area of Science:
- Genetics
- Molecular Biology
- Oncology
Background:
- The homologous recombinational repair (HRR) pathway is essential for maintaining genomic stability.
- Defects in HRR genes are linked to various genetic disorders predisposing to cancer.
- Somatic mutations in HRR genes contribute to carcinogenesis.
Purpose of the Study:
- To review genes and proteins involved in the HRR pathway and their role in cancer.
- To discuss chromosome instability disorders and their genetic basis.
- To explore the signaling pathways mediated by ATM kinase in DNA damage response.
Main Methods:
- Literature review of genes and proteins in the HRR pathway.
- Analysis of genetic disorders associated with HRR defects (e.g., AT, NBS, FA, Bloom, Werner syndromes).
- Discussion of DNA damage response pathways, focusing on double-strand breaks (DSBs).
Main Results:
- Genes like ATM, NBS, Mre11, BLM, WRN, BRCA1, and BRCA2 are critical for HRR and chromosome stability.
- Deficiencies in these genes result in chromosome instability disorders and increased cancer susceptibility.
- ATM kinase plays a central role in signaling pathways, including cell cycle checkpoints and DNA repair.
Conclusions:
- HRR pathway integrity is vital for preventing cancer development.
- Understanding HRR gene functions and associated disorders is crucial for cancer research and therapy.
- Dysfunctional DNA damage response, particularly DSB repair, can initiate and exacerbate karyotypic abnormalities, promoting cancer.